Dena Thayer, DO
Plastic and Reconstructive Surgery · Muskegon, MINPI 1306809546
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Integra Lifesciences Corporation at 57.8% of the total. 2025 is the largest year on record at $1,909, more than ten times the $84 reported in 2019.
Across 39 payments — averaging $73.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Mentor Worldwide LLC$397
- AbbVie$358
- Stryker$215
- Lemaitre Vascular, Inc.$85
- Acelrx Pharmaceuticals, Inc.$49
- plus $111 from 5 others
What the payments were for
- Food & beverage$1,25744%
- Other$1,62156%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 5 | $1,665 |
| Mentor Worldwide LLC | 10 | $397 |
| AbbVie(2 entities) | 11 | $358 |
| Stryker | 3 | $215 |
| Lemaitre Vascular, Inc. | 2 | $85 |
| Acelrx Pharmaceuticals, Inc. | 2 | $49 |
| Smith+Nephew | 2 | $36 |
| Shockwave Medical, Inc | 1 | $22 |
| Axogen | 1 | $19 |
| Merz North America, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,879 in reported general payments places this provider in the 55th percentile of 55 plastic and reconstructive surgery providers in Michigan.
See all plastic and reconstructive surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 34 | $1,968 |
| SsdSilver Sulfadiazine | 42 | $589 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $160 |
| Cephalexin | 29 | $124 |
| Mupirocin | 11 | $90 |
| Tramadol Hcl | 50 | $33 |
| Gabapentin | 13 | $31 |
| Ibuprofen | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Muskegon
- Stephen ZoncaMuskegon$2K
- Michael MeiningerBloomfield Hills$152K
- Dunya AtishaDetroit$74K
- Barak TanzmanBerkley$70K
- Firas KarmoPontiac$47K
- Melek KayserSaint Clair Shores$28K
- Theodore KungAnn Arbor$19K
- Pravin PuriTroy$16K
- Christopher LumleyBingham Farms$15K
- Maristella EvangelistaDetroit$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.